Alterola Biotech (Alterola Biotech) Interest Expense : $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Alterola Biotech Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Alterola Biotech's interest expense for the three months ended in Dec. 2023 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Alterola Biotech's Operating Income for the three months ended in Dec. 2023 was $ -1.11 Mil. Alterola Biotech's Interest Expense for the three months ended in Dec. 2023 was $ 0.00 Mil. Alterola Biotech has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Alterola Biotech Interest Expense Historical Data

The historical data trend for Alterola Biotech's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alterola Biotech Interest Expense Chart

Alterola Biotech Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Mar22

Mar23

Interest Expense

Get a 7-Day Free Trial

-0.01

Alterola Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

Alterola Biotech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Alterola Biotech (OTCPK:ABTI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Alterola Biotech's Interest Expense for the three months ended in Dec. 2023 was $0.00 Mil. Its Operating Income for the three months ended in Dec. 2023 was $-1.11 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $0.00 Mil.

Alterola Biotech's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Alterola Biotech had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Alterola Biotech (Alterola Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alterola Biotech Inc (OTCPK:ABTI) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

47 Hamilton Square, Birkenhead, Merseyside, GBR, CH41 5AR

Website

https://www.alterolabio.com

Alterola Biotech Inc is a development stage company. The company develops chewing gums to deliver nutraceutical/functional ingredients for applications such as appetite suppressant, cholesterol suppressant, vitamin delivery, antioxidant delivery, and motion sickness suppressant.

Executives

Bright Green Corp

10 percent owner

401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301